-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vinflunine for the treatment of metastatic transitional cell carcinoma: recent evidence from clinical trials and observational studies
Camille Serrate, Damien Pouessel, Helene Gauthier, Christine le Maignan, Luis Teixeira & Stephane Culine
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation